drugset / Trial / NCT05696977
Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study aims to assess the effect of obesity on therapeutic response and safety of cyclosporine trough level in nephrotic syndrome patients and calculating a suitable weight-based dose.
Timeline
- Start
- 2022-04-17
- Primary completion
- 2024-02
- Completion
- 2024-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 3 mg/kg | — |